Pharmacokinetic PK

Related by string. pharmacokinetics PK * Pharmacokinetics . pharmacokinetics . pharmacokinetic : pharmacokinetic PK . safety tolerability pharmacokinetics . favorable pharmacokinetic profile . safety tolerability pharmacokinetic / PKs . Pk . PKS : Lt Gen PK Rath . PK Subban Yannick Weber . PK Banerjee * pharmacokinetic PK study . pharmacokinetic PK profile . formal pharmacokinetic PK *

Related by context. Frequent words. (Click for all words.) 75 Pharmacokinetic 69 Immunogenicity 66 pharmacodynamic effects 66 Carfilzomib 65 Clinical Trial Results 64 Pivotal Phase III 64 Phase Ib clinical 64 Tolerability 64 C Reactive Protein 63 vitro experiments 63 Pharmacokinetics 63 Bortezomib 63 pharmacodynamic 63 Azedra 63 PS# [001] 63 Pivotal Phase 62 DAVANAT 62 immunohistochemical 62 PCK# 62 SABCS 61 Metastatic Melanoma 61 nab paclitaxel 61 ISIS # 61 Monotherapy 61 Solid Tumors 61 CR# vcMMAE 61 elotuzumab 61 Benign Prostatic Hyperplasia 61 rNAPc2 61 EZN 61 CCX# 61 Meta Analysis 61 Pioglitazone 61 biodistribution 61 SCH # 61 Drug Candidate 61 radiolabeled 60 secondary efficacy endpoints 60 TG# [001] 60 pharmacokinetic 60 Voreloxin 60 Phase III Clinical Trial 60 PXD# 60 Phase 1a 60 CA4P 60 inhibitory effects 60 genotypic 60 peripheral blood mononuclear 60 pharmacokinetic studies 60 Phase Ib 60 AEZS 60 Microspheres 60 Homocysteine 59 mRNA expression 59 TNF α 59 Rosuvastatin 59 Monoclonal Antibody 59 Phase Ia 59 subgroup analyzes 59 OXi# 59 Phase 1b trial 59 BAL# [001] 59 Preclinical studies 59 Arch Neurol 59 HuMax CD# 59 thymalfasin 59 orally bioavailable 59 Perifosine 59 Sym# 59 Phase III Trial 59 xenograft models 59 RGB # 58 genotoxicity 58 MAP# 58 Amrubicin 58 MORAb 58 Low Dose 58 Lenalidomide 58 Cethromycin 58 vitro studies 58 Multicenter 58 pharmacokinetic profiles 58 imetelstat 58 phase IIa 58 pharmacokinetic profile 58 antitumor activity 58 Phase IIa 58 microRNA expression 58 histopathological 58 CoFactor 58 induces apoptosis 58 rHuPH# 58 PK PD 58 adecatumumab 58 Trastuzumab 58 Phase 1b 58 aclidinium 58 Phase 2a trial 58 GV# [001] 58 laquinimod 58 Phase IIa trial

Back to home page